Caris Life Sciences, Inc. Common Stock (CAI)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $6.02B
Last updated: Nov 17, 2026 at 4:35 PM ET
Caris Life Sciences, Inc. Common Stock (CAI) Statistics
Caris Life Sciences, Inc. Common Stock (CAI) has a market cap of $6.02B. It earned $96.06M on revenue of $1.05B over the last 12 months.
Total Valuation
| Market Cap | $6.02B |
|---|---|
| Latest price (Nov 17, 2026) | $19.94 |
Key Dates
The next earnings report is expected on Feb 24, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Feb 24, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 4, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 5.4x and 8.9x.
| Forward P/E | 165.7x |
|---|---|
| P/S Ratio | 5.4x |
| Forward P/S | 5.8x |
| P/B Ratio | 8.9x |
| P/TBV Ratio | 9.1x |
| P/FCF Ratio | 195.8x |
| P/OCF Ratio | 71.8x |
Price Statistics
The stock is down 16.39% over 52 weeks and trades 31.74% below its 50-day average.
| Beta (1Y) | 2.01 |
|---|---|
| 52-Week Change | -16.39% |
| 1-Month Change | -35.07% |
| 3-Month Change | -12.39% |
| 6-Month Change | +33.29% |
| Total Return (1Y) | -16.39% |
| Return vs SPY (1Y) | -27.64% |
| Max Drawdown (1Y) | -49.58% |
| Sharpe Ratio (1Y) | -0.25 |
| Correlation with SPY (1Y) | 0.39 |
| 50-Day Average | $29.21 |
| 200-Day Average | $21.60 |
| 52-Week Range | $14.19 to $36.50 |
| RSI (14 Days) | 25.4 |
| Average Volume (20 Days) | 4.10M |
Financial Position
Current assets cover 6.71x current liabilities, and total debt is 0.61x shareholder equity.
| Current Ratio | 6.71x |
|---|---|
| Quick Ratio | 5.84x |
| Debt / Equity | 0.61x |
| Debt / FCF | 13.60x |
Returns and Efficiency
| Return on Capital Employed (ROCE) | 10.96% |
|---|---|
| Asset Turnover | 0.94x |
| Inventory Turnover | 2.47x |
| Receivables Turnover | 8.38x |
| Cash Conversion Cycle | 107 days |
Taxes
Income tax took 1.55% of pretax income over the last 12 months.
| Income Tax (TTM) | $1.51M |
|---|---|
| Effective Tax Rate | 1.55% |
Scores
CAI has a Piotroski F-Score of 6 of 9, in the average band of 3 to 7.
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Piotroski F-Score | 6 of 9 |
|---|---|
| Piotroski Strength | Average |
Income Statement
Revenue was $1.05B over the last 12 months.
| Revenue | $1.05B |
|---|---|
| Gross Profit | $724.14M |
| Operating Income | $139.94M |
| Pretax Income | $97.57M |
| Net Income | $96.06M |
| EBITDA | $145.96M |
| EBIT | $120.23M |
| Reported EPS (TTM) | -$0.21 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 50.75% of the $1.26B in total assets.
| Total Debt | $393.27M |
|---|---|
| Working Capital | $908.32M |
| Shareholder Equity | $639.48M |
| Book Value Per Share | $2.25 |
| Tangible Book Value | $620.14M |
| Tangible Book Per Share | $2.18 |
| Total Assets | $1.26B |
| Total Liabilities | $616.14M |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $54.98M of capital spending, operating cash flow left $28.91M of free cash flow.
| Operating Cash Flow | $83.89M |
|---|---|
| Capital Expenditures | $54.98M |
| Free Cash Flow | $28.91M |
| FCF Per Share | $0.10 |
| Depreciation and Amortization | $26.34M |
| Share Repurchases | $31.46M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is 13.35%.
| Gross Margin | 69.09% |
|---|---|
| Operating Margin | 13.35% |
| Pretax Margin | 9.31% |
| Net Margin | 9.16% |
| EBITDA Margin | 13.93% |
| EBIT Margin | 11.47% |
| FCF Margin | 2.76% |
Dividends and Yields
CAI does not pay a dividend. Its free cash flow yield is 0.51%.
| FCF Yield | 0.51% |
|---|---|
| Buyback Yield | 0.56% |
| Shareholder Yield | 0.56% |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About CAI
What is CAI's market cap?
Caris Life Sciences, Inc. Common Stock has a market cap of $6.02B.
How many shares of CAI are outstanding?
Caris Life Sciences, Inc. Common Stock has 283.89M shares outstanding. The count is up 0.64% from a year earlier.
Does CAI pay a dividend?
No. Caris Life Sciences, Inc. Common Stock does not pay a dividend.
CAI pages: Overview, Forecast, Financials, Statistics, Valuation, Competitors